ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

Zacks Equity Research
Zacks Rank can tell you which stocks to buy and sell. Zacks Equity Research tells you why. Click here to learn more.

Quote:

Search for Ticker

Free Membership

Search:

ALGN: Align Technology Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

ALIGN TECHNOLOGY INC (NASD)
ALGN	15.81	N/A	(N/A%)	Vol. 0	N/A ET

Align Technology Inc. designs, manufactures and markets the Invisalign System, a proprietary method for treating malocclusion. The System corrects malocclusion using a series of clear, removable appliances that gently move teeth to a desired final position. Because it does not rely on the use of metal or ceramic brackets and wires, the System significantly reduces the aesthetic and other limitations associated with braces. The Invisalign System also offers orthodontists a new means of carrying out their diagnosis and treatment planning processes.

General Information

ALIGN TECH INC

881 Martin Avenue Santa Clara, CA 95050 Phone: 408-470-1000 Fax: 408-470-1010 Web: www.aligntech.com Email: investorinfo@aligntech.com

Industry	MED/DENTAL-SUPP
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	01/27/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	15.81
52 Week High	18.85
52 Week Low	6.10
Beta	2.14
20 Day Moving Average	657,229.06
Target Price Consensus	18.63

% Price Change
4 Week	-12.20
12 Week	15.11
YTD	77.60

% Price Change Relative to S&P 500
4 Week	-13.15
12 Week	8.52
YTD	46.99

Share Information
Shares Outstanding (millions)	66.66
Market Capitalization (millions)	1,035.90
Short Ratio	8.89
Last Split Date	N/A

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.09
Current Year EPS Consensus Estimate	0.32
Estimated Long-Term EPS Growth Rate	22.50
Next EPS Report Date	01/27/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	1.86
30 Days Ago	2.00
60 Days Ago	2.14
90 Days Ago	2.67

Fundamental Ratios

P/E
Current FY Estimate:	48.72
Trailing 12 Months:	48.56
PEG Ratio	2.17

EPS Growth
vs. Previous Year	18.18%
vs. Previous Quarter	85.71%

Sales Growth
vs. Previous Year	5.45%
vs. Previous Quarter:	3.87%

Price Ratios
Price/Book	4.02
Price/Cash Flow	30.24
Price / Sales	3.45

ROE
09/30/09	9.27
06/30/09	9.65
03/31/09	10.22

ROA
09/30/09	7.23
06/30/09	7.45
03/31/09	7.80

Current Ratio
09/30/09	3.26
06/30/09	3.06
03/31/09	3.14

Quick Ratio
09/30/09	3.23
06/30/09	3.03
03/31/09	3.11

Operating Margin
09/30/09	7.28
06/30/09	6.88
03/31/09	6.53

Net Margin
09/30/09	-15.68
06/30/09	6.56
03/31/09	5.65

Pre-Tax Margin
09/30/09	-15.68
06/30/09	6.56
03/31/09	5.65

Book Value
09/30/09	3.87
06/30/09	3.59
03/31/09	3.45

Inventory Turnover
09/30/09	38.03
06/30/09	32.72
03/31/09	30.55

Debt-to-Equity
09/30/09	-
06/30/09	0.00
03/31/09	0.00

Debt to Capital
09/30/09	-
06/30/09	0.00
03/31/09	0.00


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research